| Year |
Citation |
Score |
| 2022 |
Vashistha A, Kumar S, Kirar S, Sharma N, Das B, Banerjee UC, Pawar SV, Kumar R, Yadav AK. Synthesis, biological evaluation and in silico studies of 2-aminoquinolines and 1-aminoisoquinolines as antimicrobial agents. Computational Biology and Chemistry. 102: 107807. PMID 36587565 DOI: 10.1016/j.compbiolchem.2022.107807 |
0.326 |
|
| 2021 |
Sisodiya S, Paul S, Chaudhary H, Grewal P, Kumar G, Daniel DP, Das B, Nayak D, Guchhait SK, Kundu CN, Banerjee UC. Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and Apoptotic effects. Bioorganic & Medicinal Chemistry Letters. 128274. PMID 34303812 DOI: 10.1016/j.bmcl.2021.128274 |
0.744 |
|
| 2020 |
Kadagathur M, Devi GP, Grewal P, Sigalapalli DK, Makhal PN, Banerjee UC, Bathini NB, Tangellamudi ND. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies. Bioorganic Chemistry. 99: 103629. PMID 32272367 DOI: 10.1016/j.bioorg.2020.103629 |
0.469 |
|
| 2019 |
Joshi G, Kalra S, Yadav UP, Sharma P, Singh PK, Amrutkar S, Ansari AJ, Kumar S, Sharon A, Sharma S, Sawant DM, Banerjee UC, Singh S, Kumar R. E-pharmacophore guided discovery of pyrazolo[1,5-c]quinazolines as dual inhibitors of topoisomerase-I and histone deacetylase. Bioorganic Chemistry. 103409. PMID 31732194 DOI: 10.1016/J.Bioorg.2019.103409 |
0.773 |
|
| 2019 |
Kumar R, Saha N, Purohit P, Garg SK, Seth K, Meena VS, Dubey S, Dave K, Goyal R, Sharma SS, Banerjee UC, Chakraborti AK. Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities. European Journal of Medicinal Chemistry. 182: 111601. PMID 31445233 DOI: 10.1016/J.Ejmech.2019.111601 |
0.331 |
|
| 2018 |
Sehajpal P, Kirar S, Ghosh S, Banerjee UC. Generation of novel family of reductases from PCR based library for the synthesis of chiral alcohols and amines. Enzyme and Microbial Technology. 118: 83-91. PMID 30143204 DOI: 10.1016/J.Enzmictec.2018.07.006 |
0.319 |
|
| 2018 |
Kaur G, Cholia RP, Joshi G, Amrutkar SM, Kalra S, Mantha AK, Banerjee UC, Kumar R. Anticancer activity of dihydropyrazolo[1,5-c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase II. Archiv Der Pharmazie. PMID 29737542 DOI: 10.1002/Ardp.201800023 |
0.777 |
|
| 2016 |
Priyadarshani G, Nayak A, Amrutkar SM, Das S, Guchhait SK, Kundu CN, Banerjee UC. Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents. Acs Medicinal Chemistry Letters. 7: 1056-1061. PMID 27994737 DOI: 10.1021/Acsmedchemlett.6B00242 |
0.758 |
|
| 2016 |
Priyadarshani G, Amrutkar S, Nayak A, Banerjee UC, Kundu CN, Guchhait SK. Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα. European Journal of Medicinal Chemistry. 122: 43-54. PMID 27343852 DOI: 10.1016/J.Ejmech.2016.06.024 |
0.763 |
|
| 2016 |
Darpan D, Joshi G, Amrutkar SM, Baviskar AT, Kler H, Singh S, Banerjee UC, Kumar R. Synthesis and biological evaluation of new 2,5-dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors Rsc Advances. 6: 14880-14892. DOI: 10.1039/C5Ra25705K |
0.75 |
|
| 2015 |
Tripathy D, Choudhary A, Banerjee UC, Singh IP, Chatterjee A. Induction of Apoptosis and Reduction of Endogenous Glutathione Level by the Ethyl-Acetate Soluble Fraction of the Methanol Extract of the Roots of Potentilla fulgens in Cancer Cells. Plos One. 10: e0135890. PMID 26284809 DOI: 10.1371/journal.pone.0135890 |
0.309 |
|
| 2015 |
Negi A, Alex JM, Amrutkar SM, Baviskar AT, Joshi G, Singh S, Banerjee UC, Kumar R. Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-α inhibition. Bioorganic & Medicinal Chemistry. PMID 26216018 DOI: 10.1016/J.Bmc.2015.07.020 |
0.784 |
|
| 2015 |
Baviskar AT, Amrutkar SM, Trivedi N, Chaudhary V, Nayak A, Guchhait SK, Banerjee UC, Bharatam PV, Kundu CN. Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors. Acs Medicinal Chemistry Letters. 6: 481-5. PMID 25941559 DOI: 10.1021/Acsmedchemlett.5B00040 |
0.733 |
|
| 2013 |
Baviskar AT, Banerjee UC, Gupta M, Singh R, Kumar S, Gupta MK, Kumar S, Raut SK, Khullar M, Singh S, Kumar R. Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity. Bioorganic & Medicinal Chemistry. 21: 5782-93. PMID 23920485 DOI: 10.1016/j.bmc.2013.07.016 |
0.355 |
|
| 2013 |
Kashyap M, Kandekar S, Baviskar AT, Das D, Preet R, Mohapatra P, Satapathy SR, Siddharth S, Guchhait SK, Kundu CN, Banerjee UC. Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents. Bioorganic & Medicinal Chemistry Letters. 23: 934-8. PMID 23321564 DOI: 10.1016/J.Bmcl.2012.12.063 |
0.72 |
|
| 2013 |
Amrutkar SM, Banoth L, Banerjee UC. One-pot synthesis of (R)-1-(1-naphthyl)ethanol by stereoinversion using Candida parapsilosis Tetrahedron Letters. 54: 3274-3277. DOI: 10.1016/J.Tetlet.2013.04.051 |
0.696 |
|
| 2011 |
Nepali K, Agarwal A, Sapra S, Mittal V, Kumar R, Banerjee UC, Gupta MK, Satti NK, Suri OP, Dhar KL. N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry. 19: 5569-76. PMID 21862335 DOI: 10.1016/j.bmc.2011.07.039 |
0.436 |
|
| 2011 |
Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait SK, Kundu CN, Banerjee UC, Bharatam PV. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase. Journal of Medicinal Chemistry. 54: 5013-30. PMID 21644529 DOI: 10.1021/Jm200235U |
0.757 |
|
| 2011 |
Nepali K, Singh G, Turan A, Agarwal A, Sapra S, Kumar R, Banerjee UC, Verma PK, Satti NK, Gupta MK, Suri OP, Dhar KL. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry. 19: 1950-8. PMID 21353569 DOI: 10.1016/j.bmc.2011.01.058 |
0.409 |
|
| Show low-probability matches. |